This development is based on a press release statement and represents an ongoing effort to enhance cancer diagnostics through less invasive methods, with the potential to impact treatment strategies ...
BioView and ScreenCell inked a commercial collaboration that will apply BioView’s Automated Cell Imaging Systems to image circulating tumor cells (CTCs) isolated using ScreenCell’s CytoKit® platform.
Hosted on MSN
ANGLE partners with BioView
ANGLE (OTCQX:ANPCY) signs an agreement with BioView to develop a liquid biopsy circulating tumor cell (or CTC) HER2 assay for breast cancer. It will be utilising ANGLE's FDA cleared Parsortix PC1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results